CT 996
Alternative Names: CT-996; RG-6652Latest Information Update: 22 Jul 2024
At a glance
- Originator Carmot Therapeutics
- Class Antihyperglycaemics; Obesity therapies; Small molecules
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Obesity; Type 2 diabetes mellitus